Home › Funds › Capital Research Global Investors › ABBV

Capital Research Global Investors position in ABBV

ABBVIE INC · Health Care

Capital Research Global Investors reported holding 31,115,872 shares of ABBV (ABBVIE INC) in its Q3 2026 13F filing — a position valued at US$8.14B, representing 1.17% of its reported portfolio and ranking #20 among its reported holdings. Capital Research Global Investors has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)31.12M sh
Reported value held$8.14B
Portfolio Weight1.17%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Capital Research Global Investors's ABBV position evolved

Capital Research Global Investors first disclosed a stake in ABBV in Q3 2023 at 31,976,144 shares (US$4.77B). The position peaked in Q3 2026 at 31,115,872 shares, worth US$8.14B. Across 13 filings, Capital Research Global Investors increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 31,115,872 shares valued at US$8.14B — an increase of 1,014,321 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 31.98M $4.77B New
Q4 2023 30.30M $4.70B Reduce
Q1 2024 31.30M $5.70B Add
Q2 2024 33.19M $5.69B Add
Q3 2024 33.21M $6.56B Hold
Q4 2024 33.98M $6.04B Add
Q1 2025 33.51M $7.02B Reduce
Q2 2025 25.27M $4.69B Reduce
Q3 2025 25.23M $5.84B Hold
Q4 2025 25.41M $5.81B Add
Q1 2026 31.25M $6.80B Add
Q2 2026 30.10M $7.57B Reduce
Q3 2026 31.12M $8.14B Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (ABBVIE INC) is a Health Care company. 30 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$30.26B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has Capital Research Global Investors held ABBV?

Capital Research Global Investors has disclosed ABBV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Capital Research Global Investors's current position in ABBV?

As of Q3 2026, Capital Research Global Investors holds 31.12M shares of ABBV (ABBVIE INC), valued at $8.14B, representing 1.17% of its reported portfolio and ranking #20.

Has Capital Research Global Investors been buying or selling ABBV?

In the latest 13F filing (Q3 2026), Capital Research Global Investors increased its position in ABBV. The position peaked in Q3 2026 at 31.12M shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.